News
AIMD
0.5396
-1.89%
-0.0104
Weekly Report: what happened at AIMD last week (0428-0502)?
Weekly Report · 4d ago
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga · 04/30 21:05
Ainos forms partnership with ASE Chung Li
TipRanks · 04/30 13:29
Weekly Report: what happened at AIMD last week (0421-0425)?
Weekly Report · 04/28 10:12
Ainos, ugo complete first robotic smell integration in Japan
TipRanks · 04/21 12:21
Weekly Report: what happened at AIMD last week (0414-0418)?
Weekly Report · 04/21 10:12
Ainos secures TFDA approval, IRB clearance to advance VELDONA trials
TipRanks · 04/14 12:30
Ainos advances Veldona oral interferon drug platform
TipRanks · 04/14 12:22
Weekly Report: what happened at AIMD last week (0407-0411)?
Weekly Report · 04/14 10:07
Weekly Report: what happened at AIMD last week (0331-0404)?
Weekly Report · 04/07 10:06
Based on the provided financial report articles, I generated the title for the article: "Annual Report (Form 10-K) for the fiscal year ended December 31, 2024, of [Company Name]" Please note that the title may not be exact, as the provided text appears to be a financial report in XML format, and the title may not be explicitly stated.
Press release · 04/07 06:55
Weekly Report: what happened at AIMD last week (0324-0328)?
Weekly Report · 03/31 10:12
Weekly Report: what happened at AIMD last week (0317-0321)?
Weekly Report · 03/24 10:06
Weekly Report: what happened at AIMD last week (0310-0314)?
Weekly Report · 03/17 10:11
Weekly Report: what happened at AIMD last week (0303-0307)?
Weekly Report · 03/10 10:12
Ainos, Inc. Reports 2024 Financial Results and Strategic Shift
TipRanks · 03/09 03:51
Based on the provided financial report articles, I generated the title for the article: "Annual Report (Form 10-K) for the fiscal year ended December 31, 2024, of [Company Name]" Please note that the title may not be exact, as the provided text appears to be a financial report in XML format, and the title may not be explicitly stated.
Press release · 03/07 22:38
Ainos reports FY results
Seeking Alpha · 03/07 22:17
AINOS INC - COLLABORATION TO DIGITIZE SMELL FOR ROBOTS
Reuters · 03/05 21:50
Ainos And Ugo Announce A Strategic Partnership To Integrate Ainos' AI Nose Technology With Ugo's Autonomous Robotic Platform; Collaboration Will Mark A Major Milestone In The Digitization Of Smell, Unlocking New Capabilities For Robots In Industrial Safety, Healthcare, And Public Security
Benzinga · 03/05 15:25
More
Webull provides a variety of real-time AIMD stock news. You can receive the latest news about Ainos Inc through multiple platforms. This information may help you make smarter investment decisions.
About AIMD
More
Ainos, Inc. is a diversified healthcare company, which is focused on the development of point-of-care testing (POCT), low-dose VELDONA interferon therapeutics and synthetic Ribonucleic Acid (RNA)-driven preventative medicine. Its product pipeline includes VELDONA clinical-stage human therapeutics, VELDONA Pet cytoprotein health supplements, and telehealth-friendly POCTs powered by its AI Nose technology platform. VELDONA Pet is formulated to address a variety of health issues in dogs and cats, including skin, gum, emotion, discomfort caused by allergies, eye, and weight-related issues. Its pipeline of products, which are under development, includes VELDONA human and animal drugs, VOC POCT-Ainos Flora, VOC platform-NISD co-development, VOC POCT-Ainos Pen, VOC POCT-CHS430 and Synthetic RNA. VELDONA human drugs are the high-priority programs include oral warts for human immunodeficiency virus seropositive patients, common cold, influenza and Sjogrens syndrome.